Expert Opinion on Investigational Drugs · 2009 · 32 citations · 29 references
MedicineEndocrinologyPharmacotherapyInfertilityReproductive EndocrinologyReproductive PhysiologyAndrogen DeficiencyGonadal DisordersGonadal HormonesMale InfertilityMale Reproductive EndocrinologyReproductive PharmacologyGonadal Axis DysfunctionHormonal PharmacologyHypothalamic-pituitary Axis DysfunctionHypothalamic-pituitary-gonadal Axis DisruptionHypothalamic-pituitary-gonadal Axis DysfunctionHypothalamic-pituitary-gonadal Axis RegulationPituitary DysfunctionSecondary Hypogonadism
Hypogonadism has a number of important clinical consequences related to androgen deficiency and impaired spermatogenesis. The cause of this condition is multifactorial and can result from hypothalamic, pituitary or gonadal dysfunction as well as factors that affect hormonal signaling along the hypothalamic-pituitary-gonadal axis. While testosterone replacement is the most common treatment, it can paradoxically lead to infertility, and may be a less physiologic therapy for patients with secondary hypogonadism due to pituitary dysfunction. Clomiphene citrate, and its derivatives, may allow for restoration of gonadal function by restoring physiologic pituitary function in a subset of patients with hypogonadism.
29
Association between premature mortality and hypopituitarism
N Holden, Keith Wheatley, RN Clayton et al. · The Lancet · 2001 · 1K citations
Shalender Bhasin, Glenn R. Cunningham, Frances J. Hayes et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 973 citations · Full text
Medicine, Endocrinology, Andrology +16
Laurence Katznelson, Joel S. Finkelstein, David Schoenfeld et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 733 citations · Full text
Medicine, Endocrinology, Andrology +16